AHENK lab Listed by Deadlock Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

On July 28, 2026, the ransomware group known as Deadlock listed AHENK lab, also identified as Ahenk Laboratuvarı, among the organisations it claims to have attacked. Public reporting states that internal files were exfiltrated in a ransomware incident. The number of people affected remains unknown, and further operational details have not been disclosed.

Because AHENK lab is a medical laboratory handling clinical and diagnostic work, any confirmed exposure of internal material carries potential consequences for patients, partner clinics, and the laboratory itself. At present the public record rests largely on the group’s leak-site claim and the limited summary that accompanies it.

What happened

According to the available record, Deadlock listed AHENK lab on or about July 28, 2026. The listing characterises the incident as a ransomware attack in which internal files were taken. No confirmed figure for the volume of data, no technical description of the intrusion method, and no timeline of when the intrusion began or when encryption or exfiltration occurred have been made public. The number of individuals whose information may be involved is listed as unknown. Beyond the group’s claim and the statement that internal files were exfiltrated, independent verification of the full scope has not been published.

Inside Deadlock

Deadlock is a ransomware operation that has appeared in public reporting as a double-extortion group: actors encrypt systems and simultaneously remove copies of data, then threaten to publish or sell the material if a ransom is not paid. Like other groups in this category, Deadlock has used dedicated leak sites to name alleged victims and, in some cases, to release samples or larger archives when negotiations stall. Public analyses of the group’s activity describe typical ransomware tradecraft—initial access through common vectors such as compromised credentials or vulnerable remote services, followed by lateral movement, data staging, and deployment of encryptors—though the precise path used against any single victim is rarely confirmed without forensic disclosure from the victim or investigators.

In this instance, Deadlock’s listing of AHENK lab constitutes a claim by the group. No independent confirmation that the laboratory’s systems were encrypted, that a ransom demand was issued, or that the full contents of any exfiltrated archive match what the group may later publish has been included in the facts available for this report. Readers should treat assertions originating solely from a ransomware leak site with appropriate caution until corroborated.

Who is AHENK lab?

Ahenk Laboratuvarı is an ISO 15189-accredited medical laboratory based in Istanbul-Şişli, Turkey. Founded in 1998, it provides services in clinical biochemistry, microbiology, pathology, and genetics. The laboratory collaborates with Limbach Laboratories in Germany. Organisations of this type routinely process patient specimens, generate diagnostic reports, maintain quality and accreditation records, and exchange data with referring physicians, hospitals, and international partners.

A breach affecting such a laboratory is consequential because the data it holds is often sensitive by nature—linked to individuals’ health status, test results, and identifying particulars—and because disruption can affect diagnostic turnaround and trust in the laboratory’s operations. ISO 15189 accreditation underscores that the laboratory operates under formal quality and competence standards; any security incident therefore also raises questions about continuity of those controls, even when the precise technical cause remains undisclosed.

The information in question

The facts state that internal files were exfiltrated in the ransomware attack. No further inventory—file names, database tables, record counts, or categories such as patient demographics, test results, or staff records—has been publicly itemised in the material provided. Exact contents therefore remain unconfirmed.

Medical laboratories of this kind typically hold patient identifiers, referral information, laboratory information-system records, analytical results across biochemistry, microbiology, pathology and genetics, quality-control documentation, and correspondence with clinicians and partner laboratories. They may also retain employee and contractor data, billing or insurance-related information, and technical configuration files. Whether any or all of these categories were among the internal files claimed by Deadlock has not been established in the public record. Until a detailed disclosure or independent analysis appears, it is not possible to state with certainty what specific data types left the organisation’s control.

What's at stake

For individuals whose information may have been involved, the primary risks are misuse of personal and health-related data: targeted phishing that references genuine test or appointment details, identity fraud, or unwanted exposure of sensitive medical findings. Even partial records can be combined with data from other breaches to build more convincing social-engineering attempts. Because the scale of affected people is unknown, it is not yet clear how widely these risks extend.

For AHENK lab, the stakes include operational disruption if systems were encrypted, potential regulatory and accreditation scrutiny, reputational harm, and the cost of investigation, containment, and notification. Collaboration with an international partner such as Limbach Laboratories may also require coordinated assessment of any shared data flows. None of these outcomes is confirmed solely by a leak-site listing; they represent the concrete possibilities that follow when a medical laboratory is named in a ransomware claim involving exfiltrated internal files.

If your data was in this breach

If you have been a patient, referring clinician, or employee connected with AHENK lab, treat the situation as a precautionary matter rather than confirmed personal exposure. Monitor financial and medical correspondence for unexpected messages that appear to reference laboratory services. Consider placing fraud alerts with relevant credit or identity services where available in your jurisdiction, and be cautious about unsolicited requests for additional personal information. Change passwords on any accounts that may have reused credentials associated with the laboratory, and enable multi-factor authentication where it is offered.

You can also run a free exposure scan of your email address to check whether your information has already surfaced in known breach datasets. That step does not confirm or rule out involvement in this specific incident, but it can indicate whether your details appear in broader collections of compromised data and help you prioritise further protective measures.

AICompiled with AI assistance from public sources and published under our editorial standards.